Pirfenidone Prevents Myocarditis by Restoring Metabolic Hormone Levels in a Mouse MASH Model and its Effect on H9c2 Myoblast Viability under Glucolipotoxicity
Introduction and Objectives: Obesity, global epidemic, can cause metabolic dysfunction-associated steatohepatitis (MASH) and cardiovascular diseases. Pirfenidone (PFD) has anti-inflammatory and anti-fibrotic properties. We investigated the effects of PFD on metabolic hormones expression and myocardi...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2025-04-01
|
| Series: | Annals of Hepatology |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1665268125000675 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|